Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

Overexpression of alpha(1)-acid glycoprotein in transgenic mice leads to sensitisation to acute colitis.

Hochepied T, Wullaert A, Berger FG, Baumann H, Brouckaert P, Steidler L, Libert C.

Gut. 2002 Sep;51(3):398-404.

2.

Attenuated mild colonic inflammation and improved survival from severe DSS-colitis of transgenic Cu/Zn-SOD mice.

Kruidenier L, van Meeteren ME, Kuiper I, Jaarsma D, Lamers CB, Zijlstra FJ, Verspaget HW.

Free Radic Biol Med. 2003 Mar 15;34(6):753-65.

PMID:
12633752
3.

Role of interleukin 15 in colitis induced by dextran sulphate sodium in mice.

Yoshihara K, Yajima T, Kubo C, Yoshikai Y.

Gut. 2006 Mar;55(3):334-41. Epub 2005 Sep 14.

4.

Osteopontin deficiency protects mice from Dextran sodium sulfate-induced colitis.

Zhong J, Eckhardt ER, Oz HS, Bruemmer D, de Villiers WJ.

Inflamm Bowel Dis. 2006 Aug;12(8):790-6.

PMID:
16917234
5.

The role of the complement and contact systems in the dextran sulfate sodium-induced colitis model: the effect of C1 inhibitor in inflammatory bowel disease.

Lu F, Fernandes SM, Davis AE 3rd.

Am J Physiol Gastrointest Liver Physiol. 2010 Jun;298(6):G878-83. doi: 10.1152/ajpgi.00400.2009. Epub 2010 Mar 25.

6.

High-level constitutive expression of alpha 1-acid glycoprotein and lack of protection against tumor necrosis factor-induced lethal shock in transgenic mice.

Libert C, Hochepied T, Berger FG, Baumann H, Fiers W, Brouckaert P.

Transgenic Res. 1998 Nov;7(6):429-35.

PMID:
10341451
7.

Dextran sulfate sodium-induced acute colonic inflammation in angiotensin II type 1a receptor deficient mice.

Katada K, Yoshida N, Suzuki T, Okuda T, Mizushima K, Takagi T, Ichikawa H, Naito Y, Cepinskas G, Yoshikawa T.

Inflamm Res. 2008 Feb;57(2):84-91. doi: 10.1007/s00011-007-7098-y.

PMID:
18288458
8.

The PPARgamma agonist rosiglitazone impairs colonic inflammation in mice with experimental colitis.

Ramakers JD, Verstege MI, Thuijls G, Te Velde AA, Mensink RP, Plat J.

J Clin Immunol. 2007 May;27(3):275-83. Epub 2007 Feb 14.

9.

Efficacy of drugs used in the treatment of IBD and combinations thereof in acute DSS-induced colitis in mice.

Sann H, Erichsen Jv, Hessmann M, Pahl A, Hoffmeyer A.

Life Sci. 2013 Apr 9;92(12):708-18. doi: 10.1016/j.lfs.2013.01.028. Epub 2013 Feb 8.

PMID:
23399699
10.

Transgenic over-expression of macrophage migration inhibitory factor renders mice markedly more susceptible to experimental colitis.

Ohkawara T, Miyashita K, Nishihira J, Mitsuyama K, Takeda H, Kato M, Kondo N, Yamasaki Y, Sata M, Yoshiki T, Sugiyama T, Asaka M.

Clin Exp Immunol. 2005 May;140(2):241-8.

11.

Psychological stress reactivates dextran sulfate sodium-induced chronic colitis in mice.

Melgar S, Engström K, Jägervall A, Martinez V.

Stress. 2008 Sep;11(5):348-62. doi: 10.1080/10253890701820166.

PMID:
18666024
12.

Human thioredoxin-1 ameliorates experimental murine colitis in association with suppressed macrophage inhibitory factor production.

Tamaki H, Nakamura H, Nishio A, Nakase H, Ueno S, Uza N, Kido M, Inoue S, Mikami S, Asada M, Kiriya K, Kitamura H, Ohashi S, Fukui T, Kawasaki K, Matsuura M, Ishii Y, Okazaki K, Yodoi J, Chiba T.

Gastroenterology. 2006 Oct;131(4):1110-21. Epub 2006 Aug 9.

PMID:
17030181
13.

Dextran sulphate sodium induces acute colitis and alters hepatic function in hamsters.

Karlsson A, Jägervall A, Pettersson M, Andersson AK, Gillberg PG, Melgar S.

Int Immunopharmacol. 2008 Jan;8(1):20-7. Epub 2007 Oct 29.

PMID:
18068096
14.

Interferon-gamma is causatively involved in experimental inflammatory bowel disease in mice.

Ito R, Shin-Ya M, Kishida T, Urano A, Takada R, Sakagami J, Imanishi J, Kita M, Ueda Y, Iwakura Y, Kataoka K, Okanoue T, Mazda O.

Clin Exp Immunol. 2006 Nov;146(2):330-8.

15.

Suppression of experimental colitis by intestinal mononuclear phagocytes.

Qualls JE, Kaplan AM, van Rooijen N, Cohen DA.

J Leukoc Biol. 2006 Oct;80(4):802-15. Epub 2006 Aug 3.

PMID:
16888083
16.

Increased susceptibility to dextran sulfate sodium induced colitis in the T cell protein tyrosine phosphatase heterozygous mouse.

Hassan SW, Doody KM, Hardy S, Uetani N, Cournoyer D, Tremblay ML.

PLoS One. 2010 Jan 25;5(1):e8868. doi: 10.1371/journal.pone.0008868.

17.

Reduced susceptibility of mice overexpressing transforming growth factor alpha to dextran sodium sulphate induced colitis.

Egger B, Carey HV, Procaccino F, Chai NN, Sandgren EP, Lakshmanan J, Buslon VS, French SW, Büchler MW, Eysselein VE.

Gut. 1998 Jul;43(1):64-70.

18.

Enhanced intestinal inflammation induced by dextran sulfate sodium in tumor necrosis factor-alpha deficient mice.

Naito Y, Takagi T, Handa O, Ishikawa T, Nakagawa S, Yamaguchi T, Yoshida N, Minami M, Kita M, Imanishi J, Yoshikawa T.

J Gastroenterol Hepatol. 2003 May;18(5):560-9.

PMID:
12702049
19.

VPAC1 (vasoactive intestinal peptide (VIP) receptor type 1) G protein-coupled receptor mediation of VIP enhancement of murine experimental colitis.

Yadav M, Huang MC, Goetzl EJ.

Cell Immunol. 2011;267(2):124-32. doi: 10.1016/j.cellimm.2011.01.001. Epub 2011 Jan 7.

PMID:
21295288
20.

Supplemental Content

Support Center